1 · Baseline glucose tolerance
Before any sweetener, the trial measured glucose tolerance, microbiome and blood metabolites in every participant: tolerance was normal, but microbiomes differed from person to person.Starting point (Suez 2014 + 2022):· Suez 2022 (Cell): a in 120 healthy adults, supplemented for 2 weeks
· Baseline measured first: a glucose tolerance test (how fast blood glucose comes back down after a dose of sugar) + stool and oral microbiome + blood metabolites
Baseline state:
· Glucose curve: normal glucose tolerance (2-hour glucose < 7.8 mmol/L)
· Microbiome: different in every person, which is where the later individual differences come from
Key background: the zero-glycemic-index reasoning:
· Classic nutrition reasoned: no sugar, so no effect on blood glucose
· The hidden premise is that sugar is the only direct route to blood glucose
· The two Suez studies challenge that premise — sweeteners can affect blood glucose in some people indirectly, through the microbiome
· This is not a defence of sugar — sugar's own problems are unchanged
The two studies differ in scale:
· 2014: mouse experiments + a small trial in 7 people for about a week
· 2022: a randomized trial in 120 people over 2 weeks — milder effects, and they vary from person to person